Actively Recruiting
Comparing 150cm OAGB With 150cm Biliopancreatic Limb RYGB. A Non-inferiority Trial
Led by Flevoziekenhuis · Updated on 2024-04-23
298
Participants Needed
2
Research Sites
411 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The purpose of this study is to assess the safety and efficiency of OAGB compared to RYGB
CONDITIONS
Official Title
Comparing 150cm OAGB With 150cm Biliopancreatic Limb RYGB. A Non-inferiority Trial
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Body-mass index (BMI) of 40 kg/m2 or higher, or 35 kg/m2 or higher with at least one comorbidity such as type 2 diabetes, high blood pressure, obstructive sleep apnoea, dyslipidaemia, or osteoarthritis of the hip or knee
- Positive evaluation by the bariatric multidisciplinary team (BMDT)
- Age between 18 and 65 years
You will not qualify if you...
- Presence of H. Pylori infection resistant to eradication therapy
- Chronic diarrhoea
- History of previous bariatric or extensive abdominal surgery
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Flevoziekenhuis
Almere Stad, Netherlands, 1315RA
Actively Recruiting
2
OLVG
Amsterdam, Netherlands, 1061AE
Not Yet Recruiting
Research Team
S
Stef JM Smeets, MD PhD
CONTACT
F
Floris Bruinsma, Student
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here